Suppr超能文献

miR-489通过靶向PROX1在人类胃癌中发挥肿瘤抑制作用。

miR-489 acts as a tumor suppressor in human gastric cancer by targeting PROX1.

作者信息

Zhang Bin, Ji Sheqing, Ma Fei, Ma Qi, Lu Xianzhi, Chen Xiaobing

机构信息

Department of General Surgery, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, China.

出版信息

Am J Cancer Res. 2016 Sep 1;6(9):2021-2030. eCollection 2016.

Abstract

Dysregulation of microRNAs (miRNAs) are linked to tumorigenesis and tumor progression. In this study, we examined the expression of miR-489 in gastric cancer tissues and cells. Loss- and gain-of-function experiments were done to determine the roles of miR-489 in gastric cancer cell proliferation and invasion. Bioinformatic prediction, luciferase reporter assays, and Western blot analysis were employed to identify the target gene(s) of miR-489. We found that miR-489 was significantly ( < 0.05) downregulated in human gastric cancer tissues and cell lines, compared to their non-malignant counterparts. Enforced expression of miR-489 significantly suppressed gastric cancer cell proliferation and invasion, while miR-489 knockdown enhanced the aggressive behaviors of gastric cancer cells. Prospero homeobox 1 (PROX1) was identified to be a direct target of miR-489. A significant negative correlation was seen between miR-489 and PROX1 protein expression in gastric cancer tissues ( = -0.462, = 0.023). Silencing of PROX1 phenocopied the suppressive effects of miR-489 in gastric cancer cells. Rescue experiments demonstrated that overexpression of a miR-489-resistant form of PROX1 significantly prevented the reduction in cell proliferation and invasion induced by miR-489 overexpression. In vivo studies confirmed that miR-489 overexpression retarded the growth of xenograft tumors, which was accompanied by reduced PROX1 expression. Overall, these data provide evidence for the suppressive activity of miR-489 in gastric cancer, which is ascribed to targeting of PROX1. The miR-489/PROX1 axis may represent a potential therapeutic target for this disease.

摘要

微小RNA(miRNA)失调与肿瘤发生和肿瘤进展相关。在本研究中,我们检测了miR - 489在胃癌组织和细胞中的表达。进行了功能丧失和功能获得实验,以确定miR - 489在胃癌细胞增殖和侵袭中的作用。采用生物信息学预测、荧光素酶报告基因检测和蛋白质印迹分析来鉴定miR - 489的靶基因。我们发现,与非恶性对应物相比,miR - 489在人胃癌组织和细胞系中显著下调(<0.05)。miR - 489的强制表达显著抑制胃癌细胞增殖和侵袭,而miR - 489敲低则增强了胃癌细胞的侵袭性行为。Prospero同源盒1(PROX1)被鉴定为miR - 489的直接靶标。在胃癌组织中,miR - 489与PROX1蛋白表达之间存在显著负相关(=-0.462,=0.023)。PROX1沉默模拟了miR - 489对胃癌细胞的抑制作用。拯救实验表明,miR - 489抗性形式的PROX1过表达显著阻止了miR - 489过表达诱导的细胞增殖和侵袭减少。体内研究证实,miR - 489过表达抑制了异种移植肿瘤的生长,同时伴有PROX1表达降低。总体而言,这些数据为miR - 489在胃癌中的抑制活性提供了证据,这归因于其对PROX1的靶向作用。miR - 489/PROX1轴可能代表该疾病的潜在治疗靶点。

相似文献

引用本文的文献

本文引用的文献

5
MicroRNA Targeting to Modulate Tumor Microenvironment.靶向微小RNA以调节肿瘤微环境。
Front Oncol. 2016 Jan 19;6:3. doi: 10.3389/fonc.2016.00003. eCollection 2016.
8
Surgical management of advanced gastric cancer: An evolving issue.进展期胃癌的外科治疗:一个不断发展的问题。
Eur J Surg Oncol. 2016 Jan;42(1):18-27. doi: 10.1016/j.ejso.2015.10.016. Epub 2015 Nov 14.
9
miR-543 promotes gastric cancer cell proliferation by targeting SIRT1.微小RNA-543通过靶向沉默调节蛋白1促进胃癌细胞增殖。
Biochem Biophys Res Commun. 2016 Jan 1;469(1):15-21. doi: 10.1016/j.bbrc.2015.11.062. Epub 2015 Nov 22.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验